» Articles » PMID: 35128217

Micro RNAs As Potential Biomarkers in Tuberculosis: A Systematic Review

Overview
Date 2022 Feb 7
PMID 35128217
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis (TB) remains a major infectious disease across the globe. With increasing TB infections and a rise in multi-drug resistance, rapid diagnostic modalities are required to achieve TB control. Radiological investigations and microbiological tests (microscopic examination, cartridge-based nucleic acid amplification tests, and cultures) are most commonly used to diagnose TB. Histopathological/cytopathological examinations are also required for an accurate diagnosis in many patients. The causative agent, (Mtb), is known to circumvent the host's immune system. Circulating microRNAs (miRNAs) play a crucial role in biological pathways and can be used as a potential biomarker to detect tuberculosis. miRNAs are small non-coding RNAs and negatively regulate gene expression during post-transcriptional regulation. The differential expression of miRNAs in multiple clinical samples in tuberculosis patients may be helpful as potential disease biomarkers. This review summarizes the literature on miRNAs in various clinical samples as biomarkers for TB diagnosis.

Citing Articles

Unlocking the potential of miRNAs in detecting pulmonary tuberculosis: prospects and pitfalls.

Arya R, Kumar S, Vinetz J, Kim J, Chaurasia R Expert Rev Mol Med. 2024; 26:e32.

PMID: 39639643 PMC: 11629464. DOI: 10.1017/erm.2024.29.


miR-29 as diagnostic biomarkers for tuberculosis: a systematic review and meta-analysis.

He J, Xiong J, Huang Y Front Public Health. 2024; 12:1384510.

PMID: 38807999 PMC: 11130415. DOI: 10.3389/fpubh.2024.1384510.


A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis.

Gunasekaran H, Sampath P, Thiruvengadam K, Malaisamy M, Ramasamy R, Ranganathan U BMC Infect Dis. 2024; 24(1):402.

PMID: 38622570 PMC: 11017603. DOI: 10.1186/s12879-024-09232-0.


microRNA hsa-miR-425-5p and hsa-miR-4523 expressions as biomarkers of active pulmonary tuberculosis, latent tuberculosis infection, and lymph node tuberculosis.

Massi M, Hidayah N, Handayani I, Iskandar I, Djannah F, Angria N Noncoding RNA Res. 2023; 8(4):527-533.

PMID: 37555010 PMC: 10405153. DOI: 10.1016/j.ncrna.2023.07.001.


Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis.

Sampath P, Moorthy M, Menon A, Madhav L, Janaki A, Dhanapal M Front Immunol. 2023; 14:1197805.

PMID: 37457712 PMC: 10345223. DOI: 10.3389/fimmu.2023.1197805.


References
1.
Wu J, Lu C, Diao N, Zhang S, Wang S, Wang F . Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Hum Immunol. 2011; 73(1):31-7. DOI: 10.1016/j.humimm.2011.10.003. View

2.
Wang C, Yang S, Liu C, Jiang T, Chen Z, Tu H . Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis. Tuberculosis (Edinb). 2018; 108:26-34. DOI: 10.1016/j.tube.2017.08.010. View

3.
Xu P, Wu Q, Yu J, Rao Y, Kou Z, Fang G . A Systematic Way to Infer the Regulation Relations of miRNAs on Target Genes and Critical miRNAs in Cancers. Front Genet. 2020; 11:278. PMC: 7136563. DOI: 10.3389/fgene.2020.00278. View

4.
Liang S, Song Z, Wu Y, Gao Y, Gao M, Liu F . MicroRNA-27b Modulates Inflammatory Response and Apoptosis during Infection. J Immunol. 2018; 200(10):3506-3518. DOI: 10.4049/jimmunol.1701448. View

5.
Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L . Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A. 2009; 106(13):5282-7. PMC: 2664036. DOI: 10.1073/pnas.0810909106. View